ClinicalTrials.gg
Sign In
Drug

Tedizolid phosphate clinical trials

Also written TR-701 FA, MK-1986 and Sivextro.

A product of Tedizolid; its studies count on that page too.

studies test it
29
open now
1
in phase 3
6
first study started
2008

How each study uses tedizolid phosphate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the tedizolid phosphate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Jun 2014 · SIVEXTRO · NDA 205435 (FDA, Drugs@FDA)
European Union
23 Mar 2015 · Sivextro · EMEA/H/C/002846 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tedizolid phosphate
7
Tedizolid
3

Brand

Sivextro
4

Development codes

TR-701 FA
12
MK-1986
5
DA-7218
1
TR701-122
1

Other names

TR-701 free acid phosphate
1

Studies by the year they started

29 studies that test it; most in 2012 (5)

Studies that test tedizolid phosphate, by start year
YearStudies
20084
20091
20103
20114
20125
20131
20142
20153
20161
20181
20192
20221
20231

By phase

A phase 1/2 study counts in both.

Phase 1
18
Phase 2
3
Phase 3
6
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Skin Diseases, Bacterial
3
Bacterial Infections
2
Gram-Positive Bacterial Infections
1
Pneumonia
1
Skin Diseases, Infectious
1
Cellulitis
1
Obesity
1
Tuberculosis, Multidrug-Resistant
1

Who runs them

Industry 26 · Other 3

Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (17) · Merck Sharp & Dohme LLC (5) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (2) · Tourcoing Hospital (1) · Dong-A ST Co., Ltd. (1) · Bayer (1) · Amit.Pai (1) · Assistance Publique - Hôpitaux de Paris (1)

Often tested with

Tested in the same studies.

Tyramine (1) · Midazolam (1) · Rosuvastatin (1) · Linezolid (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses tedizolid phosphate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 29

See all 29 studies that test tedizolid phosphate →

Given beside what is tested · 1 — tedizolid phosphate is usual care or a partner of the new treatment

Codes

What other systems call tedizolid phosphate · ClinicalTrials.gg INT004993

  • MeSH (NLM) C515040tedizolid phosphateConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) O7DRJ6R4DWTEDIZOLID PHOSPHATEConfirmed FDA, NLM, Wikidata
  • RxNorm 1540824Confirmed FDA, Wikidata
  • Wikidata Q21011227tedizolid phosphateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152537Tedizolid PhosphateOne source FDA
  • DrugBank DB09042One source Wikidata

Also registered as torezolid phosphate disodium (UNII 0SVV6ZD7JQ).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.